Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 97

1.

Response of Symptomatic Persistent Chronic Disseminated Candidiasis to Corticosteroid Therapy in Immunosuppressed Pediatric Patients: Case Study and Review of the Literature.

Shkalim-Zemer V, Levi I, Fischer S, Tamary H, Yakobovich J, Avrahami G, Gilad G, Elitzur S, Yaniv I, Elhasid R, Manistersky M, Shalit I.

Pediatr Infect Dis J. 2018 Jul;37(7):686-690. doi: 10.1097/INF.0000000000001844. Review.

PMID:
29140934
2.

How many OPV rounds are required to stop wild polio virus circulation in a developed country? Lessons from the Israeli experience.

Tasher D, Rahav G, Levine H, Sofer D, Linder N, Anis E, Shohat T, Manor Y, Kopel E, Shulman LM, Mendelson E, Shalit I, Somekh E.

Vaccine. 2016 Jan 12;34(3):299-301. doi: 10.1016/j.vaccine.2015.11.066. Epub 2015 Dec 9. No abstract available.

PMID:
26679402
3.

Oral Administration of OKT3 MAb to Patients with NASH, Promotes Regulatory T-cell Induction, and Alleviates Insulin Resistance: Results of a Phase IIa Blinded Placebo-Controlled Trial.

Lalazar G, Mizrahi M, Turgeman I, Adar T, Ben Ya'acov A, Shabat Y, Nimer A, Hemed N, Zolotarovya L, Lichtenstein Y, Lisovoder N, Samira S, Shalit I, Ellis R, Ilan Y.

J Clin Immunol. 2015 May;35(4):399-407. doi: 10.1007/s10875-015-0160-6. Epub 2015 Apr 17.

PMID:
25876706
4.

Oral anti-CD3 immunotherapy for HCV-nonresponders is safe, promotes regulatory T cells and decreases viral load and liver enzyme levels: results of a phase-2a placebo-controlled trial.

Halota W, Ferenci P, Kozielewicz D, Dybowska D, Lisovoder N, Samira S, Shalit I, Ellis R, Ilan Y.

J Viral Hepat. 2015 Aug;22(8):651-7. doi: 10.1111/jvh.12369. Epub 2014 Nov 21.

PMID:
25412903
5.

Distribution of fluconazole-resistant Candida bloodstream isolates among hospitals and inpatient services in Israel.

Ben-Ami R, Rahav G, Elinav H, Kassis I, Shalit I, Gottesman T, Megged O, Weinberger M, Ciobotaro P, Shitrit P, Weber G, Paz A, Miron D, Oren I, Bishara J, Block C, Keller N, Kontoyiannis DP, Giladi M; Israeli Candidaemia Study Group.

Clin Microbiol Infect. 2013 Aug;19(8):752-6. doi: 10.1111/1469-0691.12004. Epub 2012 Sep 25.

6.

Mucormycosis in a liver allograft: salvage re-transplantation and targeted immunosuppressive management.

Gurevich M, Levi I, Steinberg R, Shonfeld T, Shapiro R, Israeli M, Sprecher H, Shalit I, Mor E.

Transpl Infect Dis. 2012 Oct;14(5):E97-101. doi: 10.1111/j.1399-3062.2012.00776.x. Epub 2012 Aug 16.

PMID:
22897560
7.

Targeted fluconazole prophylaxis for high-risk very low birth weight infants.

Rolnitsky A, Levy I, Sirota L, Shalit I, Klinger G.

Eur J Pediatr. 2012 Oct;171(10):1481-7. Epub 2012 May 25.

PMID:
22628137
8.

Transcriptional and proteomic analysis of the Aspergillus fumigatus ΔprtT protease-deficient mutant.

Hagag S, Kubitschek-Barreira P, Neves GW, Amar D, Nierman W, Shalit I, Shamir R, Lopes-Bezerra L, Osherov N.

PLoS One. 2012;7(4):e33604. doi: 10.1371/journal.pone.0033604. Epub 2012 Apr 13.

9.

Antibiotic exposure as a risk factor for fluconazole-resistant Candida bloodstream infection.

Ben-Ami R, Olshtain-Pops K, Krieger M, Oren I, Bishara J, Dan M, Wiener-Well Y, Weinberger M, Zimhony O, Chowers M, Weber G, Potasman I, Chazan B, Kassis I, Shalit I, Block C, Keller N, Kontoyiannis DP, Giladi M; Israeli Candidemia Study Group.

Antimicrob Agents Chemother. 2012 May;56(5):2518-23. doi: 10.1128/AAC.05947-11. Epub 2012 Feb 6.

10.

Inducible clindamycin resistance among methicillin-sensitive Staphylococcus aureus infections in pediatric patients.

Shouval DS, Samra Z, Shalit I, Livni G, Bilavsky E, Ofir O, Gadba R, Amir J.

Isr Med Assoc J. 2011 Oct;13(10):605-8. Erratum in: Isr Med Assoc J. 2012 Jul;14(7):464. Bilvasky, Efraim [corrected to Bilavsky, Efraim].

11.

BK-virus-associated hemorrhagic cystitis in children after hematopoietic stem cell transplantation.

Megged O, Stein J, Ben-Meir D, Shulman LM, Yaniv I, Shalit I, Levy I.

J Pediatr Hematol Oncol. 2011 Apr;33(3):190-3. doi: 10.1097/MPH.0b013e3181fce388.

PMID:
21325972
12.

Containment of a country-wide outbreak of carbapenem-resistant Klebsiella pneumoniae in Israeli hospitals via a nationally implemented intervention.

Schwaber MJ, Lev B, Israeli A, Solter E, Smollan G, Rubinovitch B, Shalit I, Carmeli Y; Israel Carbapenem-Resistant Enterobacteriaceae Working Group.

Clin Infect Dis. 2011 Apr 1;52(7):848-55. doi: 10.1093/cid/cir025. Epub 2011 Feb 11.

PMID:
21317398
13.

Moxifloxacin enhances etoposide-induced cytotoxic, apoptotic and anti-topoisomerase II effects in a human colon carcinoma cell line.

Reuveni D, Halperin D, Shalit I, Priel E, Fabian I.

Int J Oncol. 2010 Aug;37(2):463-71.

PMID:
20596674
14.

Moxifloxacin increases anti-tumor and anti-angiogenic activity of irinotecan in human xenograft tumors.

Reuveni D, Halperin D, Fabian I, Tsarfaty G, Askenasy N, Shalit I.

Biochem Pharmacol. 2010 Apr 15;79(8):1100-7. doi: 10.1016/j.bcp.2009.12.001. Epub 2009 Dec 16.

PMID:
20025849
15.

Infectious complications of peripherally inserted central venous catheters in children.

Levy I, Bendet M, Samra Z, Shalit I, Katz J.

Pediatr Infect Dis J. 2010 May;29(5):426-9. doi: 10.1097/INF.0b013e3181c94d9e.

PMID:
20016395
16.

Outcome of antibiotic lock technique for persistent central venous catheter-associated coagulase-negative Staphylococcus bacteremia in children.

Megged O, Shalit I, Yaniv I, Fisher S, Livni G, Levy I.

Eur J Clin Microbiol Infect Dis. 2010 Feb;29(2):157-61. doi: 10.1007/s10096-009-0831-4. Epub 2009 Nov 13.

PMID:
19911207
17.

Identification of novel cell wall destabilizing antifungal compounds using a conditional Aspergillus nidulans protein kinase C mutant.

Mircus G, Hagag S, Levdansky E, Sharon H, Shadkchan Y, Shalit I, Osherov N.

J Antimicrob Chemother. 2009 Oct;64(4):755-63. doi: 10.1093/jac/dkp270. Epub 2009 Jul 31.

PMID:
19648579
18.

[Should one turn over discoveries in medical science to a financial product?].

Shalit I.

Harefuah. 2009 Jan;148(1):70-2. Hebrew. No abstract available.

PMID:
19320395
19.

Risk factors for sternal wound infection in children undergoing cardiac surgery: a case-control study.

Ben-Ami E, Levy I, Katz J, Dagan O, Shalit I.

J Hosp Infect. 2008 Dec;70(4):335-40. doi: 10.1016/j.jhin.2008.08.010. Epub 2008 Oct 31.

PMID:
18951662
20.

In vitro synergy of caspofungin with licensed and novel antifungal drugs against clinical isolates of Fusarium spp.

Shalit I, Shadkchan Y, Mircus G, Osherov N.

Med Mycol. 2009;47(5):457-62. doi: 10.1080/13693780802232910.

PMID:
18720217
21.

Antibiotic use in 26 departments of internal medicine in 6 general hospitals in Israel: variability and contributing factors.

Shalit I, Low M, Levy E, Chowers M, Zimhony O, Riesenberg K, Bishara J, Raz R.

J Antimicrob Chemother. 2008 Jul;62(1):196-204. doi: 10.1093/jac/dkn150. Epub 2008 Apr 9.

PMID:
18400806
22.

Breakthrough cerebral toxoplasmosis in a patient receiving atovaquone prophylaxis after a hematopoietic stem cell transplantation.

Megged O, Shalit I, Yaniv I, Stein J, Fisher S, Levy I.

Pediatr Transplant. 2008 Dec;12(8):902-5. doi: 10.1111/j.1399-3046.2007.00891.x. Epub 2008 Jan 8.

PMID:
18194354
23.

Quinolones as enhancers of camptothecin-induced cytotoxic and anti-topoisomerase I effects.

Reuveni D, Halperin D, Shalit I, Priel E, Fabian I.

Biochem Pharmacol. 2008 Mar 15;75(6):1272-81. doi: 10.1016/j.bcp.2007.11.014. Epub 2007 Dec 3.

PMID:
18191106
24.

The epidemiology of bacteremia with febrile neutropenia: experience from a single center, 1988-2004.

Paul M, Gafter-Gvili A, Leibovici L, Bishara J, Levy I, Yaniv I, Shalit I, Samra Z, Pitlik S, Konigsberger H, Weinberger M.

Isr Med Assoc J. 2007 Jun;9(6):424-9.

26.

Immunomodulatory effects of ciprofloxacin in TNBS-induced colitis in mice.

Lahat G, Halperin D, Barazovsky E, Shalit I, Rabau M, Klausner J, Fabian I.

Inflamm Bowel Dis. 2007 May;13(5):557-65.

PMID:
17253612
27.

Moxifloxacin enhances antiproliferative and apoptotic effects of etoposide but inhibits its proinflammatory effects in THP-1 and Jurkat cells.

Fabian I, Reuveni D, Levitov A, Halperin D, Priel E, Shalit I.

Br J Cancer. 2006 Oct 23;95(8):1038-46.

28.

Moxifloxacin but not ciprofloxacin or azithromycin selectively inhibits IL-8, IL-6, ERK1/2, JNK, and NF-kappaB activation in a cystic fibrosis epithelial cell line.

Blau H, Klein K, Shalit I, Halperin D, Fabian I.

Am J Physiol Lung Cell Mol Physiol. 2007 Jan;292(1):L343-52. Epub 2006 Sep 29.

29.

Duration and outcome of persistent candidaemia in newborn infants.

Levy I, Shalit I, Askenazi S, Klinger G, Sirota L, Linder N.

Mycoses. 2006 May;49(3):197-201.

PMID:
16681810
30.

Candida endocarditis in neonates: report of five cases and review of the literature.

Levy I, Shalit I, Birk E, Sirota L, Ashkenazi S, German B, Linder N.

Mycoses. 2006 Jan;49(1):43-8.

PMID:
16367818
31.

Anti-inflammatory effects of moxifloxacin on IL-8, IL-1beta and TNF-alpha secretion and NFkappaB and MAP-kinase activation in human monocytes stimulated with Aspergillus fumigatus.

Shalit I, Halperin D, Haite D, Levitov A, Romano J, Osherov N, Fabian I.

J Antimicrob Chemother. 2006 Feb;57(2):230-5. Epub 2005 Dec 13.

PMID:
16352735
32.

Emergence of Mycobacterium simiae in respiratory specimens.

Samra Z, Kaufman L, Pitlik S, Shalit I, Bishara J.

Scand J Infect Dis. 2005;37(11-12):838-41.

PMID:
16308217
33.
34.

Moxifloxacin inhibits cytokine-induced MAP kinase and NF-kappaB activation as well as nitric oxide synthesis in a human respiratory epithelial cell line.

Werber S, Shalit I, Fabian I, Steuer G, Weiss T, Blau H.

J Antimicrob Chemother. 2005 Mar;55(3):293-300. Epub 2005 Jan 19.

PMID:
15659543
35.

Survey of tuberculin skin test positivity among Israeli pediatric hospital workers.

Finkelstein Y, Elenberg H, Chodick G, Hoffer V, Shalit I, Garty BZ.

Infect Control Hosp Epidemiol. 2004 Sep;25(9):788-91.

PMID:
15484808
36.

Voriconazole-induced QT interval prolongation and ventricular tachycardia: a non-concentration-dependent adverse effect.

Alkan Y, Haefeli WE, Burhenne J, Stein J, Yaniv I, Shalit I.

Clin Infect Dis. 2004 Sep 15;39(6):e49-52. Epub 2004 Aug 19.

PMID:
15472801
37.

Genomic approach to identification of mutations affecting caspofungin susceptibility in Saccharomyces cerevisiae.

Markovich S, Yekutiel A, Shalit I, Shadkchan Y, Osherov N.

Antimicrob Agents Chemother. 2004 Oct;48(10):3871-6.

38.

In vitro activity of caspofungin combined with sulfamethoxazole against clinical isolates of Aspergillus spp.

Yekutiel A, Shalit I, Shadkchan Y, Osherov N.

Antimicrob Agents Chemother. 2004 Sep;48(9):3279-83.

39.

Risk factors associated with candidaemia in the neonatal intensive care unit: a case-control study.

Linder N, Levit O, Klinger G, Kogan I, Levy I, Shalit I, Ashkenazi S, Sirota L.

J Hosp Infect. 2004 Aug;57(4):321-4.

PMID:
15262393
40.
41.

Disinfection with 10% povidone-iodine versus 0.5% chlorhexidine gluconate in 70% isopropanol in the neonatal intensive care unit.

Linder N, Prince S, Barzilai A, Keller N, Klinger G, Shalit I, Prince T, Sirota L.

Acta Paediatr. 2004 Feb;93(2):205-10.

PMID:
15046275
42.

Primary genital herpes simplex infection associated with Jewish ritual circumcision.

Distel R, Hofer V, Bogger-Goren S, Shalit I, Garty BZ.

Isr Med Assoc J. 2003 Dec;5(12):893-4. No abstract available.

43.

Treatment of candidaemia in premature infants: comparison of three amphotericin B preparations.

Linder N, Klinger G, Shalit I, Levy I, Ashkenazi S, Haski G, Levit O, Sirota L.

J Antimicrob Chemother. 2003 Oct;52(4):663-7. Epub 2003 Sep 12.

PMID:
12972450
44.

Immunomodulatory effects of quinolones.

Dalhoff A, Shalit I.

Lancet Infect Dis. 2003 Jun;3(6):359-71. Review.

PMID:
12781508
45.

In vitro synergy of caspofungin and itraconazole against Aspergillus spp.: MIC versus minimal effective concentration end points.

Shalit I, Shadkchan Y, Samra Z, Osherov N.

Antimicrob Agents Chemother. 2003 Apr;47(4):1416-8.

46.

Immunomodulatory and protective effects of moxifloxacin against Candida albicans-induced bronchopneumonia in mice injected with cyclophosphamide.

Shalit I, Horev-Azaria L, Fabian I, Blau H, Kariv N, Shechtman I, Alteraz H, Kletter Y.

Antimicrob Agents Chemother. 2002 Aug;46(8):2442-9.

47.

Transplanted hematopoietic cells seed in clusters in recipient bone marrow in vivo.

Askenasy N, Zorina T, Farkas DL, Shalit I.

Stem Cells. 2002;20(4):301-10.

48.

Immunomodulatory effects of moxifloxacin in comparison to ciprofloxacin and G-CSF in a murine model of cyclophosphamide-induced leukopenia.

Shalit I, Kletter Y, Halperin D, Waldman D, Vasserman E, Nagler A, Fabian I.

Eur J Haematol. 2001 May;66(5):287-96.

PMID:
11422407
49.

[Pediatric research in an office-setting network--a new dimension in pediatric research in Israel].

Grossman Z, Kahan E, Gross S, Ashkenazi S, Shalit I.

Harefuah. 1999 Jun 15;136(12):926-30, 1003. Hebrew.

PMID:
10955149
50.

Supplemental Content

Loading ...
Support Center